收藏切换
Advances in chimeric antigen receptor therapy for T cell malignant tumors
收藏切换
Xiaochen WU1, Shan HE2, Jun LU1, *
World Clinical Drug | 2022, 43(8) : 961 - 966
Less
收藏切换
World Clinical Drug | 2022, 43(8): 961-966
• Topic •
Advances in chimeric antigen receptor therapy for T cell malignant tumors
Full
Xiaochen WU1, Shan HE2, Jun LU1, *
Affiliations
  • 1.Department of Hematology, Children's Hospital of Soochow University, Suzhou 215002, Jiangsu Province, China
  • 2.Vitalgen Biopharma, Shanghai 201210, China
Published: 2022-08-10 doi: 10.13683/j.wph.2022.08.001
Outline
收藏切换

T-cell malignant tumors are characterized by high malignancy and poor prognosis. Hematopoietic stem cell transplantation is the most effective treatment approach in relapsed or refractory T-cell malignancies, which is often accompanied by severe transplantation-associated complications. Therefore, it is urgent to explore safe and effective therapies. Chimeric antigen receptor T cell therapy (CAR-T cell therapy), as a relatively novel immunotherapy method, has achieved great clinical benefits in relapsed or refractory B cell malignant tumor and multiple myeloma. Up to now, eight related drugs have been approved (6 approved by FDA and 8 approved by CFDA). However, for T-cell malignant tumors, CAR-T cell immunotherapy is still in the stages of preclinical and (or) early clinical, and faces many difficulties and challenges. This article reviewed the current research progress of CAR-T cell therapy for T cell malignancies.

T cell malignant tumor  /  chimeric antigen receptor therapy (CAR-T)  /  chimeric antigen receptor natural killer cell  /  T cell regeneration disorder
吴晓晨, 何珊, 卢俊. T细胞恶性肿瘤的嵌合抗原受体T细胞治疗研究进展. 世界临床药物, 2022 , 43 (8) : 961 -966 . DOI: 10.13683/j.wph.2022.08.001
Xiaochen WU, Shan HE, Jun LU. Advances in chimeric antigen receptor therapy for T cell malignant tumors[J]. World Clinical Drug, 2022 , 43 (8) : 961 -966 . DOI: 10.13683/j.wph.2022.08.001
Year 2022 volume 43 Issue 8
15
5
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.08.001
  • Receive Date:2022-02-13
  • Online Date:2026-11-19
  • Published:2022-08-10
Article Data
Affiliations
History
  • Received:2022-02-13
Funding
Affiliations
    1.Department of Hematology, Children's Hospital of Soochow University, Suzhou 215002, Jiangsu Province, China
    2.Vitalgen Biopharma, Shanghai 201210, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.08.001
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT